Healthcare
Galenica Reports Nine-Month Sales Rise and Confirms 2026 Guidance
Galenica grew its net revenue by 5.7% to CHF 3,172.0 million in the first nine months of 2026, supported by pharmacy and home care segments.
Roche Posts 6% Sales Growth in Nine Months Driven by Pharmaceuticals and Diagnostics
F. Hoffmann-La Roche Ltd reports group sales of CHF 46.5 billion for the first nine months of 2026, supported by strong demand for innovative medicines and diagnostics.
Roche to Showcase Phase 3 Data for Divarasib and Giredestrant at ESMO 2026
Genentech will present new trial data for oncology treatments at the European Society for Medical Oncology Annual Meeting in Madrid.
Roche puts German investments on hold amid political tensions
Swiss pharmaceutical giant Roche has halted expansion plans in Germany, citing a loss of trust over recent price-cut legislation.
Sanofi Starts Construction on Two-Billion-Euro Frankfurt Insulin Facility
Pharmaceutical company Sanofi has broken ground on a new insulin plant in Frankfurt, backed by state aid and aimed at securing European supplies.
Why Biogen, Novartis and NurExone Target the Orphan Drug Pathway
Regulatory incentives for rare diseases offer distinct commercial frameworks in the US and Europe, shaping development pathways for pharmaceutical and biotech firms.